BioVersys
Basel, CH · 2 known investors
BioVersys is a Swiss pharmaceutical company developing small-molecule drugs with novel modes of action to treat drug-resistant bacterial infections, addressing antimicrobial resistance (AMR). Its pipeline targets serious hospital infections such as A. baumannii, S. aureus, and NTM infections.